Fortescue Metals

Electric Hydrogen is a company focused on deep decarbonization by developing low-cost, high-efficiency systems for producing fossil-free hydrogen. The company targets industrial sectors such as ammonia and steel production, which contribute significantly to global greenhouse gas emissions. By rethinking electrolysis technology from scratch, Electric Hydrogen aims to make clean hydrogen competitive with traditional methods in terms of cost and scale. Their advanced PEM (Proton Exchange Membrane) technology uses renewable electricity to generate clean hydrogen gas, reducing industrial pollution and dependence on fossil fuels. The company's leadership team brings extensive experience from pioneering clean energy companies like Tesla and First Solar, positioning Electric Hydrogen as a strong contender in the quest for zero-emission industrial processes.

Austal specializes in designing, constructing, and supporting innovative defense and commercial vessels. The company focuses on aluminum shipbuilding technology.

Williams Advanced Engineering, a division of the Williams Group, specializes in providing advanced technology and engineering services to a wide range of industries. With a focus on innovation and cutting-edge solutions, the company leverages its expertise to deliver high-performance products and services to its clients. By combining its engineering capabilities with state-of-the-art technology, Williams Advanced Engineering helps businesses across various sectors optimize their operations and achieve their goals.

HyET group create technologies that enable commercially viable, large scale access to decentral renewable energy sources. The primary objective of the HyET group is to develop a sustainable and profitable business based on the above objective.

Nullagine mine was in production for five years before weak iron ore prices forced it to be shuttered in December last year.

Coridon is a privately held company based in Brisbane, Australia, founded in 2000. The company focuses on the development of DNA therapies aimed at preventing and treating viral infections, including Herpesvirus and Hepatitis C, as well as therapeutic vaccines for cancer treatment. Coridon's innovative approach involves creating DNA vaccines that target diseases such as influenza and hepatitis C, providing patients with advanced options for curing both acute and chronic conditions. Through its research and development efforts, Coridon seeks to contribute significantly to the field of medicine with its pioneering therapies.